FATAL QUARTET OR QUINTET?
https://doi.org/10.17650/1818-8338-2011-4-88-90
Abstract
Correction of potential risk factors is essential for effective therapy for cardiovascular diseases. This clinical case demonstrates negative impact of non-corrected risk factors — obstructive sleep apnea — in occurrence and further progression of cardiovascular disease.
About the Authors
Y. V. Sviryaev
FSI Almazov Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
L. S. Korostovtseva
FSI Almazov Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
A. D. Zvartau
FSI Almazov Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
E. V. Mighty
FSI Almazov Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
E. V. Vitkovskaya
FSI Almazov Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
S. A. Conradi
FSI Almazov Federal Heart, Blood and Endocrinology Centre
Russian Federation
Russian Federation
A. L. Kalinkin
Clinical Hospital № 83 FMBA
Russian Federation
Russian Federation
References
1. Mancia G., De Backer G., Dominiczak A., et al.; The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462–536.
2. Partinen M., Jamieson A., Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988; 94:1200–4.
3. Guilleminault C., Connolly S.J., Winkle R.A. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;52:490–4.
4. Gami A.S., Howard D.E., Olson E.J., Somers V.K. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352:1206–14.
5. Wolf J., Lewicka J., Narkiewicz K. Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Nutr Metab Cardiovasc Dis 2007;17:233–40.
6. Shivalkar B., Van de Heyning C., Kerremans M., et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 2006;47:1433–9.
7. Mills P.J., Dimsdale J.E. Sleep apnea: a model for studying cytokines, sleep, and sleep disruption. Brain Behav Immun 2004;18:298–303.
8. Harbison J., O'Reilly P., McNicholas W.T. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000;118:591–5.
Review
For citations:
Sviryaev Y.V., Korostovtseva L.S., Zvartau A.D., Mighty E.V., Vitkovskaya E.V., Conradi S.A., Kalinkin A.L. FATAL QUARTET OR QUINTET? The Clinician. 2011;5(4):88-90. (In Russ.) https://doi.org/10.17650/1818-8338-2011-4-88-90
Views:
955
Email this article 